Calcium, parathyroid hormone, and vitamin D: Major determinants of chronic pain in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 8, 2009, Pages 1374-1380

  Golan, Eliezer ^a,b   Haggiag, Isabelle ^a   Os, Pnina ^a   Bernheim, Jacques ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARAB; ARTICLE; BODY MASS; BRIEF PAIN INVENTORY; CALCIUM BLOOD LEVEL; CHRONIC PAIN; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ETHNIC GROUP; FEMALE; GENDER; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MINERAL METABOLISM; PROSPECTIVE STUDY; SMOKING HABIT; TREATMENT DURATION; VASCULAR ACCESS; BLOOD; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PAIN; PAIN ASSESSMENT; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

AGED; BIOLOGICAL MARKERS; CALCITRIOL; CALCIUM; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 70349931512     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00680109     Document Type: Article

References (36)

1. Davison SN: Pain in hemodialysis patients: Prevalence, cause, severity and management. Am J Kidney Dis 42: 1239-1247, 2003
2. Mercadante S, Ferrantelli A, Tortorici C, Lo Cascio A, Lo Cicero M, Cutaia I, Parrino I, Casuccio A: Incidence of chronic pain in patients with end-stage renal disease on dialysis. J Pain Symptom Manage 30: 302-304, 2005
3. Shayamsunder AK, Patel SS, Jain V, Peterson RA, Kimmel PL: Sleepiness, sleeplessness, and pain in end-stage renal disease: Distressing symptoms for patients. Semin Dial 18: 109-118, 2005
4. Murtagh FE, Addington-Hall J, Higginson IJ: The prevalence of symptoms in end stage renal disease: A systematic review. Adv Chronic Kidney Dis 14: 82-99, 2007
5. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA: Validation of World Health Organization guidelines for cancer pain relief: A 10-year prospective study. Pain 63: 65-76, 1995
6. Ahmad S, Barakzoy AS, Moss AH: Efficacy of the World Health Organization analgesic ladder to treat pain in endstage renal disease. J Am Soc Nephrol 17: 3198-3203, 2006
7. Cohen LM, Moss AH, Weisbord SD, Germain MJ: Renal palliative care. J Palliat Med 9: 977-992, 2006
8. Davison SN: Chronic pain in end-stage renal disease. Adv Chronic Kidney Dis 12: 326-334, 2005
9. Bailie GR, Mason NA, Bragg-Gresham Jl, Gillespie BW, Young EW: Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription. Kidney Int 56: 2419-2425, 2004
10. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4; 1205-1213, 1993
11. Larue F, Colleau SM, Brasseur L, Cleeland CS: Multicentre study of cancer pain and its treatment in France. BMJ 310: 1034-1037, 1995
12. Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S: The Norwegian Brief Pain Inventory questionnaire: Translation and validation in cancer pain patients. J Pain Symptom Manage 24: 517-525, 2002
13. Mystakidou K, Mendoza T, Tsilika E, Befon S, Parpa E, Bellos G, Vlahos L, Cleeland C: Greek Brief Pain Inventory: Validation and utility in cancer pain. Oncology 60: 35-42, 2001
14. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, Shin HC, Wang XS, Cleeland CS: Development of a cancer pain assessment tool in Korea: A validation study of a Korean version of the Brief Pain Inventory. Oncology 66: 439-444, 2004
15. Ger LP, Ho ST, Sun WZ, Wang MS, Cleeland CS: Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage 15: 316-322, 1999
16. Poundja J, Fikretoglu D, Guay S, Brunet A: Validation of the French version of the Brief Pain Inventory in Canadian veterans suffering from traumatic stress. J Pain Symptom Manage 33: 720-726, 2007
17. Girard F, Chouinard P, Boudreault D, Poirier C, Richard C, Ruel M, Ferraro P: Prevalence and impact of pain on the quality of life of lung transplant recipients. Chest 130: 1535-1540, 2006
18. Lee MA, Walker RW, Hildreth TJ, Prentice WM: A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 32: 462-469, 2006
19. Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH: The scope and nature of pain in persons with multiple sclerosis. Mult Scler 12: 629-638, 2006
20. Davison SN, Jhangri GS: The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage 30: 465-473, 2005
21. Kimmel PL, Emont SL, Newmann JM, Danko H, Moss AH: ESRD patient quality of life: Symptoms, Spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis 42: 713-721, 2003
22. Wu AW, Fink NE, Marsh-Manzi JV, Meyer KB, Finkelstein FO, Chapman MM, Powe NR: Changes in quality of life during hemodialysis and peritoneal dialysis treatment: Generic and disease specific measures. J Am Soc Nephrol 15: 743-753, 2004
23. Kimmel PL, Patel SS: Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with Hemodialysis. Semin Nephrol 26: 68-79, 2006
24. Chiang CK, Peng YS, Chiang SS, Yang CS, He YH, Hung KY, Wu KD, Wu MS, Fang CC, Tsai TJ, Chen WY: Health-related quality of life of hemodialysis patients in Taiwan: A multicenter study. Blood Purif 22: 490-498, 2004
25. Cano AE, Neil AK, Kang JY, Barnabas A, Eastwood JB, Nelson SR, Hartley I, Maxwell D: Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol 102: 1990-1997, 2007
26. Antoniazzi AL, Bigal ME, Bordini CA, Tepper SJ, Speciali JG: Headache and hemodialysis: A prospective study. Headache 43: 99-102, 2003
27. Zochodne DW: Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms. Muscle Nerve 36: 144-166, 2007
28. Martinez I, Saracho R, Moina I, Montenegro J, Llach F: Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure? Nephrol Dial Transplant 13[Suppl 3]: 9-11, 1998
29. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029, 2007
30. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511, 2008
31. Plantinga LC, Fink NE, Jaar BG, Huang IC, Wu AW, Meyer KB, Powe NR: Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res 16: 755-765, 2007
32. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]:S1-S201, 2003
33. Barreto FC, Barreto DV, Moysés RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB: K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73: 771-777, 2008
34. Noordzij M, Boeschoten EW, Bos WJ, Dekker FW, Bossuyt PM, Krediet RT, Korevaar JC, NECOSAD Study Group: Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant 22: 2944-2949, 2007
35. Gribkoff VK: The role of voltage-gated calcium channels in pain and nociception. Semin Cell Dev Biol 17: 555-564, 2006
36. Mascarenhas R, Mobarhan S: Hypovitaminosis D-induced pain. Nutr Rev 62: 354-359, 2004